Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMVC is a potent G-quadruplex (G4) stabilizer and a selective telomerase inhibitor (IC50: ~0.2 μM) with anticancer activities, and it also inhibits Taq DNA polymerase (IC50: ~2.5 μM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $916 | 6-8 weeks | |
50 mg | $1,190 | 6-8 weeks | |
100 mg | $1,860 | 6-8 weeks |
Description | BMVC is a potent G-quadruplex (G4) stabilizer and a selective telomerase inhibitor (IC50: ~0.2 μM) with anticancer activities, and it also inhibits Taq DNA polymerase (IC50: ~2.5 μM). |
Targets&IC50 | Telomerase:~0.2 μM , G-quadruplex:~2.5 μM |
In vitro | BMVC (0.5 μM; 0-18 days; H1299 cells) treatment significantly increases the percentage of sub-G1-phase cells after 18 days, leading to cessation of cell growth and cell death through apoptosis. Long-term BMVC treatment induces senescence, accompanied by progressive telomere shortening and DNA damage foci detection, indicating telomere uncapping [1]. |
In vivo | The treatment of BMVC (1 mg/kg; i.p.; every 3 day; BALB/cAnN.Cg-Foxn1nu/CrlNarl mice) delays tumorigenic potential of cancer cells in vivo [1]. |
Molecular Weight | 657.33 |
Formula | C28H25I2N3 |
Cas No. | 627810-06-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.